Ranking measurement occasions by their importance (ie, their relative magnitude) for PCs (with credible lifetime SES coefficients)
| Signatures | Ranking | Posterior probability |
| Lupus (PC5) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.85 |
| CVD (PC1) | Parental SES>SES in young and mid-adulthood | 0.62 |
| Colorectal (PC3) | Parental SES>SES in young and mid-adulthood | 0.64 |
| RA (PC1) | Parental SES>SES in young and mid-adulthood | 0.94 |
| RA (PC4) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.82 |
| RA (PC5) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.44 |
| Asthma (PC2) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.66 |
| Asthma (PC3) | Parental SES>SES in young and mid-adulthood | 0.76 |
| Diabetes (PC3) | Parental SES>SES in young and mid-adulthood | 0.81 |
| Diabetes (PC5) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.87 |
| Inflammation (PC2) | Parental SES>SES in young and mid-adulthood | 0.92 |
| Inflammation (PC3) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.63 |
| Inflammation (PC4) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.83 |
| Alzheimer (PC2) | SES in mid-adulthood>parental SES | 0.62 |
| Alzheimer (PC6) | Parental SES and SES in young adulthood>SES in mid-adulthood | 0.86 |
| Ageing (PC2) | Parental SES>SES in mid-adulthood | 0.96 |
| Ageing (PC4) | SES in young adulthood>parental SES and SES in mid-adulthood | 0.86 |
CVD, cardiovascular disease; PCs, principal components; RA, rheumatoid arthritis; SES, socioeconomic status.